RT Journal Article
SR Electronic
T1 Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 1603
OP 1607
DO 10.1136/ijgc-2019-001070
VO 30
IS 10
A1 Armbrust, Robert
A1 Alavi, Sara
A1 Pirmorady, Adak
A1 Chen, Frank
A1 Colombo, Nicoletta
A1 Gultekin, Murat
A1 Hierro, Charo
A1 Lemley, Birthe
A1 Mirza, Mansoor Raza
A1 Urkmez, Esra
A1 Fotopoulou, Christina
A1 Vinzent, Jutta
A1 Gonzalez Martin, Antonio
A1 Krull, Andrea
A1 Heepe, Judith
A1 Rose, Mathias
A1 Sehouli, Jalid
YR 2020
UL http://ijgc.bmj.com/content/30/10/1603.abstract
AB Background Patients’ reported outcomes and their perspectives around their therapeutic management is a field of continuously increasing relevance in gynecological oncology. We report the results of the Berlin dialog on seven patient-reported parameters and outcomes concerning chemotherapy and maintenance treatment in patients with gynecological cancer.Methods Key opinion leaders in gynecological oncology from different European counties and representatives of leading patients’ advocate groups in Berlin held a consensus meeting in Berlin on April 6, 2019. Seven topics of interest were identified in advance around quality of life, iatrogenic toxicity, treatment decision-making processes, sexuality, participation in clinical trials, second opinion, and long-term survivors with the the following standard operating procedure for processing and discussion: (1) agreement on its relevance; (2) literature review, and (3) discussion and consensus statements.Results All main topics reached a consensus approval. The defined statements emphasized the importance of patients’ role in incorporating and establishing quality of life as an outcome parameter in clinical trials. Furthermore, discussants raised the importance of identifying new tools for reflecting patient-reported iatrogenic toxicity as well as emphasizing patients’ rights in providing personal information, access to second opinion in the decision-making process, and their participation in clinical trials.Conclusion The results of this round table meeting could help redefine perspectives on the discussed topics and the importance for therapeutic management as well as for trial designs.